The prevalence and response to therapy of Strongyloides stercoralis in patients with asthma from endemic areas

Chest. 1994 Sep;106(3):762-6. doi: 10.1378/chest.106.3.762.

Abstract

Study objective: To evaluate the prevalence and response to therapy of Strongyloides stercoralis infection in immigrant patients with asthma from areas endemic for Strongyloides.

Design and interventions: In all patients, we performed a complete history and physical examination, complete blood cell counts (CBC), S stercoralis serologic tests, spirometry, and evaluated three stool samples for ova and parasites. Patients treated for S stercoralis infection had follow-up CBC, spirometry, serologic tests, and at least three additional stool examinations to confirm eradication of the parasite.

Setting: Ambulatory and hospitalized patients who were referred to the respiratory medicine clinic of a general hospital for the evaluation and treatment of asthma.

Patients: Forty-five asthmatic adults, representing 12 endemic countries, ranging in age from 20 to 76 years, were prospectively evaluated.

Results: Six of 45 patients were infected with S stercoralis, which yielded a prevalence of 13 percent. The patients with asthma and S stercoralis infection had higher blood eosinophil counts (p = 0.006) and were younger (p = 0.006) compared with patients with only asthma. There was no difference in the duration of asthma, spirometry, or steroid use between the two groups. Patients with S stercoralis and asthma tended to be more recent immigrants (p = 0.05). Five of the six patients with S stercoralis agreed to be treated with thiabendazole but only four returned for follow-up evaluation. All four patients had eradication of S stercoralis infection confirmed by negative stool examinations and a decline in S stercoralis serology (160 +/- 25 percent vs 13 +/- 13 percent, p = 0.03). All four patients had a decline in total blood eosinophil counts (2,476 +/- 832 cells per cubic millimeter vs 551 +/- 138 cells per cubic millimeter, p = 0.03) without a clinical improvement in asthma.

Conclusions: Our data suggest that patients with asthma from areas endemic for S stercoralis, who have elevated peripheral blood eosinophil counts, should be screened for S stercoralis infection. Successful eradication of S stercoralis, however, may not result in a clinical improvement of asthma.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Animals
  • Antibodies, Helminth / blood
  • Asthma / drug therapy*
  • Asthma / ethnology*
  • Asthma / immunology
  • Asthma / parasitology
  • California / epidemiology
  • Chi-Square Distribution
  • Disease Reservoirs*
  • Feces / parasitology
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • Seroepidemiologic Studies
  • Strongyloides stercoralis* / immunology
  • Strongyloides stercoralis* / isolation & purification
  • Strongyloidiasis / drug therapy*
  • Strongyloidiasis / ethnology*
  • Strongyloidiasis / immunology
  • Strongyloidiasis / parasitology

Substances

  • Antibodies, Helminth
  • Immunoglobulin G